Influence of cytochrome P450 2D6 polymorphism on hippocampal white matter and treatment response in schizophrenia

Abstract Cytochrome P450 2D6 (CYP2D6) is expressed at high levels in the brain and plays a considerable role in the biotransformation and neurotransmission of dopamine. This raises the question of whether CYP2D6 variations and its impact on the brain can confer susceptibility to schizophrenia. We in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wonsuk Shin, Minji Bang, Anhye Kim, Doo-Yeoun Cho, Sang-Hyuk Lee
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/a182e146ab9149d396ce0dc94cd46434
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a182e146ab9149d396ce0dc94cd46434
record_format dspace
spelling oai:doaj.org-article:a182e146ab9149d396ce0dc94cd464342021-12-02T13:57:35ZInfluence of cytochrome P450 2D6 polymorphism on hippocampal white matter and treatment response in schizophrenia10.1038/s41537-020-00134-z2334-265Xhttps://doaj.org/article/a182e146ab9149d396ce0dc94cd464342021-01-01T00:00:00Zhttps://doi.org/10.1038/s41537-020-00134-zhttps://doaj.org/toc/2334-265XAbstract Cytochrome P450 2D6 (CYP2D6) is expressed at high levels in the brain and plays a considerable role in the biotransformation and neurotransmission of dopamine. This raises the question of whether CYP2D6 variations and its impact on the brain can confer susceptibility to schizophrenia. We investigated the possible links among the CYP2D6 genotype, white matter (WM) integrity of the hippocampus, and the treatment response to antipsychotic drugs in Korean patients with schizophrenia (n = 106). Brain magnetic resonance imaging and genotyping for CYP2D6 were conducted at baseline. The severity of clinical symptoms and the treatment response were assessed using the Positive and Negative Syndrome Scale (PANSS). After genotyping, 43 participants were classified as intermediate metabolizers (IM), and the remainder (n = 63) were classified as extensive metabolizers (EM). IM participants showed significantly higher fractional anisotropy (FA) values in the right hippocampus compared to EM participants. Radial diffusivity (RD) values were significantly lower in the overlapping region of the right hippocampus in the IM group than in the EM group. After 4 weeks of antipsychotic treatment, the EM group showed more improvements in positive symptoms than the IM group. FAs and RDs in the CYP2D6-associated hippocampal WM region were significantly correlated with a reduction in the positive symptom subscale of the PANSS. Greater improvements in positive symptoms were negatively associated with FAs, and positively associated with RDs in the right hippocampal region. The findings suggest that CYP26D-associated hippocampal WM alterations could be a possible endophenotype for schizophrenia that accounts for individual differences in clinical features and treatment responses.Wonsuk ShinMinji BangAnhye KimDoo-Yeoun ChoSang-Hyuk LeeNature PortfolioarticlePsychiatryRC435-571ENnpj Schizophrenia, Vol 7, Iss 1, Pp 1-7 (2021)
institution DOAJ
collection DOAJ
language EN
topic Psychiatry
RC435-571
spellingShingle Psychiatry
RC435-571
Wonsuk Shin
Minji Bang
Anhye Kim
Doo-Yeoun Cho
Sang-Hyuk Lee
Influence of cytochrome P450 2D6 polymorphism on hippocampal white matter and treatment response in schizophrenia
description Abstract Cytochrome P450 2D6 (CYP2D6) is expressed at high levels in the brain and plays a considerable role in the biotransformation and neurotransmission of dopamine. This raises the question of whether CYP2D6 variations and its impact on the brain can confer susceptibility to schizophrenia. We investigated the possible links among the CYP2D6 genotype, white matter (WM) integrity of the hippocampus, and the treatment response to antipsychotic drugs in Korean patients with schizophrenia (n = 106). Brain magnetic resonance imaging and genotyping for CYP2D6 were conducted at baseline. The severity of clinical symptoms and the treatment response were assessed using the Positive and Negative Syndrome Scale (PANSS). After genotyping, 43 participants were classified as intermediate metabolizers (IM), and the remainder (n = 63) were classified as extensive metabolizers (EM). IM participants showed significantly higher fractional anisotropy (FA) values in the right hippocampus compared to EM participants. Radial diffusivity (RD) values were significantly lower in the overlapping region of the right hippocampus in the IM group than in the EM group. After 4 weeks of antipsychotic treatment, the EM group showed more improvements in positive symptoms than the IM group. FAs and RDs in the CYP2D6-associated hippocampal WM region were significantly correlated with a reduction in the positive symptom subscale of the PANSS. Greater improvements in positive symptoms were negatively associated with FAs, and positively associated with RDs in the right hippocampal region. The findings suggest that CYP26D-associated hippocampal WM alterations could be a possible endophenotype for schizophrenia that accounts for individual differences in clinical features and treatment responses.
format article
author Wonsuk Shin
Minji Bang
Anhye Kim
Doo-Yeoun Cho
Sang-Hyuk Lee
author_facet Wonsuk Shin
Minji Bang
Anhye Kim
Doo-Yeoun Cho
Sang-Hyuk Lee
author_sort Wonsuk Shin
title Influence of cytochrome P450 2D6 polymorphism on hippocampal white matter and treatment response in schizophrenia
title_short Influence of cytochrome P450 2D6 polymorphism on hippocampal white matter and treatment response in schizophrenia
title_full Influence of cytochrome P450 2D6 polymorphism on hippocampal white matter and treatment response in schizophrenia
title_fullStr Influence of cytochrome P450 2D6 polymorphism on hippocampal white matter and treatment response in schizophrenia
title_full_unstemmed Influence of cytochrome P450 2D6 polymorphism on hippocampal white matter and treatment response in schizophrenia
title_sort influence of cytochrome p450 2d6 polymorphism on hippocampal white matter and treatment response in schizophrenia
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/a182e146ab9149d396ce0dc94cd46434
work_keys_str_mv AT wonsukshin influenceofcytochromep4502d6polymorphismonhippocampalwhitematterandtreatmentresponseinschizophrenia
AT minjibang influenceofcytochromep4502d6polymorphismonhippocampalwhitematterandtreatmentresponseinschizophrenia
AT anhyekim influenceofcytochromep4502d6polymorphismonhippocampalwhitematterandtreatmentresponseinschizophrenia
AT dooyeouncho influenceofcytochromep4502d6polymorphismonhippocampalwhitematterandtreatmentresponseinschizophrenia
AT sanghyuklee influenceofcytochromep4502d6polymorphismonhippocampalwhitematterandtreatmentresponseinschizophrenia
_version_ 1718392277579071488